Coca Leaf Craze: Stepan Co. Wants DEA Import Stamp

2026-06051 — Importer of Controlled Substances Application: Usona Institute

Usona Institute wants to become an official importer of some powerful controlled substances like mescaline and psilocybin. People who make or use these drugs can share their thoughts or ask for a hearing by April 29, 2026. This move could impact research and medical use, with no direct cost changes announced yet.

2026-05912 — Bulk Manufacturer of Controlled Substances Application: SpecGx LLC

SpecGx LLC wants to become a big-time maker of some powerful and tightly controlled drugs, including things like psilocybin and fentanyl. People and companies already registered can share their thoughts or ask for a hearing by May 26, 2026. This move could shake up how these substances are made and handled, so keep an eye on the deadlines if you’re involved!

2026-05618 — Schedules of Controlled Substances: Placement of 3-Methoxyphencyclidine (1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine) in Schedule I

Starting April 22, 2026, the DEA is putting 3-methoxyphencyclidine (3-MeO-PCP) into Schedule I, meaning it’s now officially a highly controlled substance with strict rules. This affects anyone who makes, sells, studies, or even possesses 3-MeO-PCP, who will face serious legal consequences. This move helps the U.S. follow international drug laws and keeps communities safer.

2026-05482 — Ordering Schedule I and II Controlled Substances Using DEA Form 222; Technical Amendments

If you order Schedule I or II drugs using DEA Form 222, this update clears up who can sign and manage the form—only registrants, their partners, or officers can do it. It also removes old rules about the old triplicate form, making things simpler and clearer. These fixes don’t change any big rules and take effect on March 20, 2026, so no extra costs or hassles ahead!

2026-05486 — Exempt Chemical Preparations Under the Controlled Substances Act

The Drug Enforcement Administration (DEA) just updated which chemical mixes are officially exempt from strict drug rules between September 2024 and December 2025. Companies and labs using these chemicals should check the new list to see if their products are approved or denied. You’ve got until May 19, 2026, to share your thoughts, and no extra fees are involved—just a quick review and comment if you want!

2026-05359 — Importer of Controlled Substances Application: United States Pharmacopeial Convention

The United States Pharmacopeial Convention wants to become an official importer of certain controlled substances like Cathinone and Methcathinone. If you’re a registered manufacturer or interested party, you have until April 20, 2026, to share your thoughts or ask for a hearing. This move could impact how these substances are imported and tracked, but no direct costs are mentioned.

Previous: 2026-04301 — Certain New Chemicals or Significant New Uses; Statements of Findings-November 2025 to December 2025

From November to December 2025, the EPA reviewed new chemicals and new ways to use them and found they’re unlikely to harm people or the environment. This update affects companies making or using these chemicals, letting them move forward without extra delays or costs. If you’re in the chemical business, keep an eye on these approvals to stay on track and safe!

Next: 2026-04305 — Importer of Controlled Substances Application: Patheon API Inc.

Patheon API Inc. wants to become an official importer of certain controlled substances like psilocybin and psilocyn. This affects companies involved in drug manufacturing who can comment or request a hearing by April 3, 2026. No direct costs are mentioned, but the decision could impact how these substances enter the U.S. market.